SMTL ID : 8im3.3 (2 other biounits)

Crystal structure of human HPPD complexed with compound a10

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.78 Å

Oligo State

homo-dimer

Ligands

2 x CO: COBALT (II) ION(Non-covalent)

CO.1: 5 residues within 4Å: Chain A: H.183, H.266, E.349, F.359 Ligands: 92U.2 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.183, A:E.349, A:E.349 CO.3: 5 residues within 4Å: Chain B: H.183, H.266, E.349, F.359 Ligands: 92U.4 2 PLIP interactions: 2 interactions with chain B Metal complexes: B:H.183, B:E.349

2 x 92U: [1,3-diethyl-2,2-bis(oxidanylidene)-2$l^{6},1,3-benzothiadiazol-5-yl]-(1-methyl-5-oxidanyl-pyrazol-4-yl)methanone(Non-covalent)

92U.2: 17 residues within 4Å: Chain A: H.183, V.185, S.226, P.239, Q.251, H.266, L.289, L.323, F.336, F.347, E.349, F.359, G.360, N.363, F.364, L.367 Ligands: CO.1 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.323, A:F.336, A:F.347, A:N.363, A:F.364, A:F.364, A:L.367 Hydrogen bonds: A:H.266 92U.4: 16 residues within 4Å: Chain B: H.183, V.185, P.239, Q.251, H.266, L.323, Q.334, F.336, F.347, E.349, F.359, G.360, N.363, F.364, L.367 Ligands: CO.3 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:L.323, B:F.347, B:F.359, B:N.363, B:F.364, B:L.367 Hydrogen bonds: B:Q.251, B:H.266 pi-Stacking: B:F.336

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Dong, J. et al., Structure-based discovery of pyrazole-benzothiadiazole hybrid as human HPPD inhibitors. Structure (2023)

Release Date

2023-10-18

Peptides

4-hydroxyphenylpyruvate dioxygenase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
F

B
E

4-hydroxyphenylpyruvate dioxygenase

Related Entries With Identical Sequence